{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:21:32Z","timestamp":1772166092925,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Achondroplasia is a congenital skeletal system malformation caused by missense variant of\n                      <jats:italic>FGFR3<\/jats:italic>\n                      gene with an incidence of 1 per 20,000\u201330,000 newborns, which is an autosomal dominant inheritance disease. Despite similar imaging features, the homozygous achondroplasia is absolutely lethal due to thoracic stenosis, whereas heterozygous achondroplasia does not lead to fetal death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A fetus with progressive rhizomelic short limbs and overt narrow chest was detected by prenatal ultrasound in the second trimester. Gene sequencing results of amniotic fluid sample indicated a rare missense variant NM_000142.4: c.1123G\u2009&gt;\u2009T(p.Gly375Cys), leading to a glycine to cysteine substitution. Re-sequencing confirmed that it was a heterozygous variant, and thoracic stenosis was then confirmed in the corpse by radiological examination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We identified a heterozygous variant of the\n                      <jats:italic>FGFR3<\/jats:italic>\n                      gene as the rare pathogenic variant of severe achondroplasia in a fetus. Heterozygous variants of p.Gly375Cys may have a severe phenotype similar to homozygote. It\u2019s crucial to combine prenatal ultrasound with genetic examination to differentiate heterozygous from homozygous achondroplasia. The p.Gly375Cys variant of\n                      <jats:italic>FGFR3<\/jats:italic>\n                      gene may serve as a vital target for the diagnosis of severe achondroplasia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01517-8","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T10:05:04Z","timestamp":1681898704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heterozygous variant in FGFR3 underlying severe phenotypes in the second trimester: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Shujun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingpin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"9582","key":"1517_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","volume":"370","author":"WA Horton","year":"2007","unstructured":"Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007;370(9582):162\u201372.","journal-title":"Lancet"},{"issue":"8","key":"1517_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41436-021-01165-2","volume":"23","author":"JE Hoover-Fong","year":"2021","unstructured":"Hoover-Fong JE, Alade AY, Hashmi SS, et al. Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States. Genet Med. 2021;23(8):1498\u2013505.","journal-title":"Genet Med"},{"issue":"2","key":"1517_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1148\/radiology.196.2.7617874","volume":"196","author":"MD Patel","year":"1995","unstructured":"Patel MD, Filly RA. Homozygous achondroplasia: US distinction between homozygous, heterozygous, and unaffected fetuses in the second trimester. Radiology. 1995;196(2):541\u20135.","journal-title":"Radiology"},{"issue":"11","key":"1517_CR4","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/hmg\/ddu004","volume":"23","author":"F Di Rocco","year":"2014","unstructured":"Di Rocco F, Biosse Duplan M, Heuz\u00e9 Y, Kaci N, Komla-Ebri D, Munnich A, Mugniery E, Benoist-Lasselin C, Legeai-Mallet L. FGFR3 mutation causes abnormal membranous ossification in achondroplasia. Hum Mol Genet. 2014;23(11):2914\u201325.","journal-title":"Hum Mol Genet"},{"key":"1517_CR5","doi-asserted-by":"crossref","unstructured":"Krejci P. The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate. Mutat Res Rev Mutat Res. 2014;759:40\u20138.","DOI":"10.1016\/j.mrrev.2013.11.001"},{"issue":"8","key":"1517_CR6","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/ajmg.a.37776","volume":"170","author":"SC Shelmerdine","year":"2016","unstructured":"Shelmerdine SC, Brittain H, Arthurs OJ, Calder AD. Achondroplasia: Really rhizomelic? Am J Med Genet A. 2016;170(8):2039\u201343.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1517_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00210413","volume":"96","author":"S Ikegawa","year":"1995","unstructured":"Ikegawa S, Fukushima Y, Isomura M, Takada F, Nakamura Y. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet. 1995;96(3):309\u201311.","journal-title":"Hum Genet"},{"issue":"3","key":"1517_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ajmg.1320590325","volume":"59","author":"G Nishimura","year":"1995","unstructured":"Nishimura G, Fukushima Y, Ohashi H, Ikegawa S. Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (Gly to Cys transition at codon 375). Am J Med Genet. 1995;59(3):393\u20135.","journal-title":"Am J Med Genet"},{"issue":"3","key":"1517_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF01954274","volume":"154","author":"A Superti-Furga","year":"1995","unstructured":"Superti-Furga A, Eich G, Bucher HU, et al. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 1995;154(3):215\u20139.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"1517_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.ejhg.5201700","volume":"14","author":"S Heuertz","year":"2006","unstructured":"Heuertz S, Le Merrer M, Zabel B, et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet. 2006;14(12):1240\u20137.","journal-title":"Eur J Hum Genet"},{"key":"1517_CR11","doi-asserted-by":"crossref","unstructured":"Hoover-Fong J, Scott CI, Jones MC; COMMITTEE ON GENETICS. Health supervision for people with achondroplasia. Pediatrics. 2020;145(6):e20201010.","DOI":"10.1542\/peds.2020-1010"},{"key":"1517_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115579","volume":"141","author":"L Legeai-Mallet","year":"2020","unstructured":"Legeai-Mallet L, Savarirayan R. Novel therapeutic approaches for the treatment of achondroplasia. Bone. 2020;141: 115579.","journal-title":"Bone"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01517-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T10:08:34Z","timestamp":1681898914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01517-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01517-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2370494\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were conducted according to relevant guidelines and regulations, in compliance with the \"Regulations on Ethical Review of Biomedical Research Involving Human Subjects\" (Order No. 11 of the National Health and Family Planning Commission of the People's Republic of China), the \"Quality Management Standards for Clinical Trials of Medical Devices\" (Order No. 25 of the State Food and Drug Administration and the National Health and Family Planning Commission of the People's Republic of China), the Helsinki Declaration of the World Medical Association, and the ethical principles of the International Ethical Guidelines for Biomedical Research Involving Human Subjects of CIOMS. The study was approved by the Ethics Committee of The First People\u2019s Hospital of Chongqing Liang Jiang New Area. Written informed consent to participate was obtained from the fetal parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of identifying images and other personal or clinical details was obtained from the fetal parents. And the copy of the written consent is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}